DILI-Inpt预后得分用于识别住院的特异性DILI患者,他们面临不良结果的风险.
Alisa Likhitsup1, Zemin Su2, Jody A Rule3
1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
概括
一个新的DILI住院患者得分有助于预测药物诱导的肝损伤患者的生存率. 这一分数有助于识别那些自发康复机会较低的人,指导医疗决策.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临床毒理学 临床毒理学
- 内部医学 内部医学
背景情况:
- 导致急性肝衰竭 (ALF) 的特异性药物诱导性肝损伤 (DILI) 具有很高的死亡率.
- 在严重的DILI中确定非自发生存的因素对于患者管理至关重要.
研究的目的:
- 确定与严重特异性DILI住院患者非自发生存相关的呈现特征.
- 开发和验证用于预测DILI患者预后结果的预后得分.
主要方法:
- 从急性肝衰竭研究小组 (ALFSG) 注册表 (1998-2019) 中分析了305名成年参与者.
- 开发一个多变量模型来预测21天的结果 (死亡或肝移植).
- 新的DILI住院患者得分与末期肝病模型 (MELD) 和国王学院标准的比较.
主要成果:
- 该研究包括44名急性肝损伤 (ALI) 患者和261名由于DILI而患有ALF的患者.
- 在16%的DILI病例中,草药-食补充剂参与其中.
- 与MELD (0.79) 和国王学院标准 (0.63) 相比,DILI住院患者得分显示了21天非自发生存的优异预测准确性 (AUROC 0.86),与MELD (0.79) 和国王学院标准 (0.63) 相比.
结论:
- 一个新的DILI住院患者预后得分有效地识别了自发存活风险最低的患者.
- 这一分数可以作为住院DILI患者的医疗决策的宝贵工具.
- 建议在独立队列中进一步验证.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
170
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170
01:24Dosage Regimen: Individualization
156
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
156